Condition

Relapsed/Refractory Non-Hodgkin Lymphoma clinical trials and research

• 2Clinical trials
• 15Countries

All recruiting trials (2)

• NexCAR19 (Talikabtagene Autoleucel) for relapsed or refractory B‑cell leukemias and lymphomas

  This trial will test modified versions of a patient's own T cells (NexCAR19/Talikabtagene Autoleucel) to see if they can control relapsed or refractory B‑cell leukemias and lymphomas in adults.

  Recruiting at 3 sites Phase 2/3 Health Institutes of Turkey · Ankara and 3 other locations · NCT07502118

• Assessing BMS-986458 for treating relapsed non-Hodgkin lymphoma

  This study is testing a new drug called BMS-986458 to see if it can help people with relapsed non-Hodgkin lymphoma when used alone or with standard treatments like Rituximab.

  Recruiting at 35 sites Phase 1/2 Bristol-Myers Squibb · Phoenix, Arizona and 75 other locations · NCT06090539

Related topics

Quick answers

How many Relapsed/Refractory Non-Hodgkin Lymphoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 15 countries. The most sites are in Turkey (Türkiye) (2 trials), Chile (1 trial), China (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →